United States - English - NLM (National Library of Medicine)

padagis us llc - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin cream is indicated for the treatment of inflammatory lesions of rosacea. none. risk summary the available data on the use of ivermectin, including lvermectin cream, in pregnant women are insufficient to establish a drug- associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies, ivermectin induced adverse developmental outcomes when orally administered to pregnant rats and rabbits during the period of organogenesis at doses 1909 or 354 times the maximum recommended human dose (mrhd), respectively. these orally administered doses were maternally toxic to pregnant rats and rabbits. in a pre-and postnatal developmental study in rats, neonatal toxicity and adverse effects on behavioral development were observed when lvermectin was orally administered to pregnant females during gestation and lactation (see data ). the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin cream, 1% is indicated for the treatment of inflammatory lesions of rosacea. none. pregnancy category c. there are no adequate and well-controlled studies in pregnant women. ivermectin cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. note: the animal multiples of human exposure calculations were based on auc comparisons. the maximum topical human dose (mthd) of ivermectin cream is 1 g applied once daily. systemic embryofetal development studies were conducted in rats and rabbits. oral doses of 1.5 mg/kg/day, 4 mg/kg/day, and 12 mg/kg/day ivermectin were administered during the period of organogenesis (gestational days 6 to 17) to pregnant female rats. maternal death occurred at 12 mg/kg/day (1909x mthd). cleft palate occurred in the fetuses from the 12 mg/kg/day (1909x mthd) group. no treatment related effects on embryofetal toxicity or teratogenicity were noted at 4 mg/kg/day (708x mthd). oral doses of 0.5 mg/kg/day, 1.5 mg/kg/day, 2.5

United States - English - NLM (National Library of Medicine)

department of state health services, pharmacy branch - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 3 mg - stromectol is indicated for the treatment of the following infections: strongyloidiasis of the intestinal tract . stromectol is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite strongyloides stercoralis . this indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of ivermectin. (see clinical pharmacology, clinical studies.) onchocerciasis . stromectol is indicated for the treatment of onchocerciasis due to the nematode parasite onchocerca volvulus . this indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of west africa. the comparative studies used diethylcarbamazine citrate (dec-c). note: stromectol has no activity against adult onchocerca volvulus parasites. the adult parasites resid

United States - English - NLM (National Library of Medicine)

sparhawk laboratories, inc. - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 10 mg in 1 ml - sparmectin-e (ivermectin) liquid is indicated for the effective treatment and control of the following parasites in horses. large strongyles (adults): strongylus vulgaris (also early forms in blood vessels) strongylus edentatus (also tissue stages) strongylus equinus triodontophorus spp. including: triodontophorus brevicauda    triodontophorus serratus craterostomum acuticaudatum small strongyles (adults, including those resistant to some benzimidazole class compounds): coronocyclus spp. including: coronocyclus coronatus    coronocyclus labiatus    coronocyclus labratus cyathostomum spp. including: cyathostomum catinatum    cyathostomum pateratum cylicocyclus spp. including: cylicocyclus insigne    cylicocyclus leptostomum    cylicocyclus nassatus    cylicocyclus brevicapsulatus    cylicodontophorus spp. cylicostephanus spp. including: cylicostephanus calicatus    cylicostephanus goldi    cylicostephanus longibursatus    cylicostephanus minutus pe

United States - English - NLM (National Library of Medicine)

sparhawk laboratories, inc. - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 10 mg in 1 ml - cattle :  ivermectin injection is indicated for the effective treatment and control of the following harmful species of gastrointestinal roundworms, lungworms, grubs, sucking lice and mange mites in cattle: gastrointestinal roundworms (adults and fourth-stage larvae): ostertagia ostertagi     (including inhibitedo. ostertagi ) o. lyrata haemonchus placei trichostrongylus axei t. colubriformis cooperia oncophora c. punctata c. pectinata oesophagostomum radiatum bunostomum phlebotomum nematodirus helvetianus (adults only) n. spathiger (adults only) lungworms (adults and fourth-stage larvae): dictyocaulus viviparus cattle grubs (parasitic stages): hypoderma bovis h. lineatum solenopotes capillatus sucking lice : linognathus vituli haematopinus eurysternus solenopotes capillatus mites iscabies: psoroptes ovis     (syn.p. communis var.bovis ) sarcoptes scabiei  var. bovis ivermectin injection has been proved to effectively control infections and to protect cattle from reinfection withdictyocaulus viviparus and oesophagostomum radiatum for 28 days after treatment;ostertagia ostertagi, trichostrongylus axei and cooperia punctata for 21 days after treatment;haemonchus placei and cooperia oncophora for 14 days after treatment. swine :  ivermectin injection is indicated for the effective treatment and control of the following harmful species of gastrointestinal roundworms, lungworms, lice and mange mites in swine: gastrointestinal roundworms large roundworm,ascaris suum (adults and fourth-stage larvae) red stomach worm,hyostrongylus rubidus (adults and fourth-stage larvae) nodular worm,oesophagostomum spp. (adults and fourth-stage larvae) threadworm,strongyloides ransomi (adults) somatic roundworm larvae: threadworm, strongyloides ransomi (somtic larvae) sows must be treated at least seven days before farrowing to prevent infection in piglets. lungworm: metastrongylus spp . (adults) lice: haematopinus suis mange mites: sarcoptes scabiei  var. suis

United States - English - NLM (National Library of Medicine)

galderma laboratories, l.p. - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 10 mg in 1 g - soolantra cream is indicated for the treatment of inflammatory lesions of rosacea. none. risk summary the available data on the use of ivermectin, including soolantra cream, in pregnant women are insufficient to establish a drug- associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. in animal reproduction studies, ivermectin induced adverse developmental outcomes when orally administered to pregnant rats and rabbits during the period of organogenesis at doses 1909 or 354 times the maximum recommended human dose (mrhd), respectively. these orally administered doses were maternally toxic to pregnant rats and rabbits. in a pre-and postnatal developmental study in rats, neonatal toxicity and adverse effects on behavioral development were observed when ivermectin was orally administered to pregnant females during gestation and lactation (see data). the background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies ha

United States - English - NLM (National Library of Medicine)

durvet - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 0.8 mg in 1 ml - for the treatment and control of worms and bots of sheep - 20- 100 lb doses (240 ml) - 83- 100 lb doses (960 ml) see booklet for additional information. restricted drug (california) - use only as directed for animal use only • keep out of reach of children approved by fda under anada # 200-327 manufactured for: durvet, inc. blue springs, mo u.s.a. www.durvet.com ivermectin sheep drench provides treatment and control of adult and fourth-stage larvae of the following parasites: gastrointestinal roundworms – haemonchus contortus , ostertagia circumcincta , trichostrongylus axei , t. colubriformis , cooperia curticei , nematodirus spathiger , n. battus , and oesophagostomum columbianum ; lungworms – dictyocaulus filaria ; and all the larval stages of nasal bot – oestrus ovis . it also provides treatment and control of adult forms only of the following gastrointestinal roundworms – haemonchus placei , cooperia oncophora , strongyloides papillosus , oesophagostomum venulosum , trichuris ovis , and chabertia ovina

United States - English - NLM (National Library of Medicine)

med-pharmex, inc - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin 1.87 g in 100 g - indications : consult your veterinarian for assistance in the diagnosis, treatment, and control of parasitism. ivermectin paste provides effective treatment and control of the following parasites in horses.  large strongyles (adults) – strongylus vulgaris (also early forms in blood vessels), s . edentatus (also tissue stages), s . equinus , triodontophorus spp. including t . brevicauda and t . serratus and craterostomum acuticaudatum ; small strongyles (adults, including those resistant to some benzimidazole class compounds) – coronocyclus spp. including c . coronatus , c . labiatus and c . labratus , cyathostomum spp. including c . catinatum and c . pateratum , cylicocyclus spp. including c . insigne , c . leptostomum , c . nassatus and c . brevicapsulatus , cylicodontophorus spp., cylicostephanus spp. including c . calicatus , c . goldi , c . longibursatus and c . minutus , and petrovinema poculatum ; small strongyles – fourth-stage larvae; pinworms (adults and fourth-stage larvae) – ox

United States - English - NLM (National Library of Medicine)

durvet, inc. - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d), clorsulon (unii: eg1zdo6lrd) (clorsulon - unii:eg1zdo6lrd) - indications ivermectin plus is indicated for the effective treatment and control of the following parasites in cattle: gastrointestinal roundworms  (adults and fourth-stage larvae): ostertagia ostertagi  (including inhibited o. ostertagi ) o. lyrata haemonchus placei trichostrongylus axei t. colubriformis cooperia oncophora c. punctata c. pectinata bunostomum phlebotomum nematodirus helvetianus  (adults only) n. spathiger  (adults only) oesophagostomum radiatum lungworms  (adults and fourth-stage larvae): dictyocaulus viviparus liver flukes: fasciola hepatica  (adults only) cattle grubs  (parasitic stages): hypoderma bovis h. lineatum sucking lice: linognathus vituli haematopinus eurysternus solenopotes capillatus mange mites  (cattle scab*): psoroptes ovis  (syn. p. communis  var. bovis) sarcoptes scabiei  var. bovis persistent activity ivermectin and clorsulon injection has been proved to effectively control infections and to protect cattle from reinfection with dictyocaulus viviparu

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - ivermectin (unii: 8883yp2r6d) (ivermectin - unii:8883yp2r6d) - ivermectin is indicated for the treatment of the following infections: ivermectin is indicated for the treatment of intestinal (i.e., nondisseminated) strongyloidiasis due to the nematode parasite strongyloides stercoralis . this indication is based on clinical studies of both comparative and open-label designs, in which 64-100% of infected patients were cured following a single 200-mcg/kg dose of ivermectin (see clinical pharmacology, clinical studies). ivermectin is indicated for the treatment of onchocerciasis due to the nematode parasite onchocerca volvulus . this indication is based on randomized, double-blind, placebo-controlled and comparative studies conducted in 1427 patients in onchocerciasis-endemic areas of west africa. the comparative studies used diethylcarbamazine citrate (dec-c). note: ivermectin has no activity against adult onchocerca volvulus parasites. the adult parasites reside in subcutaneous nodules which are infrequently palpable. surgical excision of these nodules (nodulectomy) may b